GridAI Technologies Corp Dossier
|
SectorInformation Technology IndustrySystems Software Beta (adjusted)1.54 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $3.44Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $24.5M Enterprise Value $25.8M Shares Outstanding 7.1M diluted All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary GridAI Technologies Corp. (formerly Entero Therapeutics, Inc.) represents a high-risk, speculative transition story. Following its acquisition of Grid AI Corp. in late 2025, the company has pivoted from a pure-play clinical-stage biopharmaceutical firm to a diversified entity operating at the intersection of artificial intelligence and energy infrastructure. While the market opportunity for AI-driven energy orchestration across hyperscale data centers is massive, the company faces severe liquidity constraints, a substantial accumulated deficit, and going concern doubts. A 'Hold' rating is recommended until the company demonstrates sustained commercial traction with its energy platform and stabilizes its balance sheet. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $1.5020% The bear case materializes if the company fails to secure additional capital, leading to a severe liquidity crunch that halts both the development of the Grid AI platform and the clinical trials for Adrulipase. This scenario could force the company to pursue extreme strategic alternatives, including asset fire sales, a wind-down, or bankruptcy. Base CaseCentral scenario $5.5055% The base case assumes slow but steady integration of the Grid AI and AMPX operations, with modest initial revenue generation from energy services. The company will likely continue to rely on highly dilutive equity financings and debt restructurings to fund its operations, keeping the stock range-bound as it works to resolve its going concern status and advance its technology platform. Bull CaseUpside scenario $8.5025% The bull case is driven by rapid commercial adoption of the Grid AI energy-orchestration platform, particularly through its partnership with Amp Z to orchestrate power across a planned portfolio of over 5GW of AI data centers. Successful commercialization of the software-first platform would generate high-margin recurring revenue, while a potential partnership or licensing deal for its legacy Phase 3-ready biopharmaceutical asset (Adrulipase) could provide non-dilutive funding. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |